Oncopharmpod
Tremelimumab & Teclistamab
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:23:26
- More information
Informações:
Synopsis
New Drug Approvals! -Tremelimumab, the 2nd CTLA-4 inhibitor, finally gets approved. -Teclistamab, an excited BCMA-CD3 T-cell engager for multiple myeloma.
